Background and Objectives: To access care, pediatric type 1 diabetes (T1D) patients living in
be similar, regardless of whether they were receiving tertiary or community care.
| METHODS
Patients were recruited from T1D clinics across BC. Inclusion criteria included: (1) physician-diagnosed T1D after 1-year of age and (2) duration of T1D for 3 or more years. Patients received a letter of invitation in the mail prior to their clinic appointment. At their clinic appointment, patients who met the inclusion criteria and their parents were approached by a research assistant requesting participation. Aiming for an even representation of the range of patient circumstances, we analyzed the demographic features of the participants on a quarterly basis and used this information to target recruitment at specific clinics.
Informed consent was obtained from all participants prior to the completion of surveys. At BCCH, 172 (30%) patients consented to participate out of 578 that were approached. This data was unavailable for community sites.
Clinical data were collected by medical chart review. Patient-level data were collected through caregiver surveys, including demographic information. Participants were asked to identify reasons that make it difficult to attend diabetes clinic appointments (barriers to care). They were provided with a list of options and asked to select all statements that applied (see supplemental online material). Odds ratios of reporting a barrier were calculated based on the first response option-'It isn't difficult to take my child to diabetes clinic appointments.' To validate the main outcome variable, if someone reported they had no barriers based on this first option but then went on to select a barrier from the subsequent choices, they were reclassified as having a barrier (n = 8). Of note, there was also an opportunity to record barriers not identified on the list using free text. The list of barriers was devised a priori by the research team and was reviewed with the diabetes team at BCCH and pediatric diabetes clinicians from diabetes centers across the province. The survey was pilot tested with a small sample of patients to ensure that the questions were easy to understand prior to its implementation. Feedback from clinicians and patients was integrated.
Clinic type was categorized as tertiary (BCCH) or community, based on self-reported primary diabetes physician. Some patients saw more than one provider for their diabetes care; however, their categorization was always based on their self-selected primary doctor. As reported by the caregivers, the travel time to BCCH was categorized as: <1 hour, 1 to 2 hours, or >2 hours. The average of the last three HbA 1C values was compared across the three aforementioned BCCH groups and the community group.
Parents were asked to complete the Diabetes Treatment Satisfaction Questionnaire (DTSQ), 5 a 13-item survey that explores satisfaction with various aspects of diabetes treatment, current glycemic control, and support from the diabetes care team. Responses range from "very dissatisfied" to "very satisfied" on a scale from 0 to 6. 5 An overall treatment satisfaction score is calculated as the sum of responses to 10 of the survey items, resulting in a maximum total score of 60. As per the scoring instructions, three of the items were not included in the total score, as they evaluated domains other than treatment satisfaction. Finally, families were asked to fill out the Adherence in Diabetes Questionnaire (ADQ). 6 There are four parental versions of this survey with 17 to 19 questions, tailored to the age of the child (2-4 years or 5-18 years) and insulin regimen (conventional treatment or insulin pump). The questionnaire evaluates selfperceived adherence to diabetes management, including insulin, diet, blood glucose monitoring, treatment of hypoglycemia/hyperglycemia, physical activity, and attendance at clinic appointments. 6 Responses range from "not at all" (1) to "always" (5) . The final score is computed as the mean of all the items, with a score of 5 indicating the highest level of adherence. 6 Children were also offered the opportunity to complete the youth versions of the DTSQ and ADQ, age-permitting.
The DTSQ teen satisfaction score includes responses to eight items (maximum score 48). 5 The child ADQ format is similar to the parent survey, with 17 to 19 questions depending on insulin regimen. Board approved the study. Table 1 summarizes patient characteristics. Among community patients, 77% (56/73) received care from a pediatric endocrinologist, of which 22% were seen by pediatric endocrinologists working at BCCH and providing community-based outreach, and the remainder by pediatric endocrinologists working in the community. Twentythree percent (17/73) received care from pediatricians. Eighty-eight percent of the community group traveled less than 1 hour to see their diabetes care provider. Patients' age and diabetes duration were comparable across groups ( Table 1) . As outlined in Table 1 , community patients were seen in clinic more often compared to tertiary patients (approximately, one extra visit per year, on average). Insulin regimen differed across the groups, with more children utilizing continuous subcutaneous insulin infusions (CSII) in the community group. Parent and teen ADQ scores were similar across the groups.
| RESULTS
Twenty-three percent of community patients and 18%, 32%, and 45% of tertiary patients traveling <1 hour, 1 to 2 hours, and >2 hours, respectively, reported ≥1 barriers to attending clinic. Distance to clinic was the most common barrier, followed by time off work ( Figure 1 ).
Compared to community patients, tertiary patients traveling >2 hours had over three times higher odds of reporting barriers to attending clinic (odds ratio 3.46; 95% confidence interval [CI]: 1.17, 10.25; adjusted for household income) ( Table 2 ). There were no significant differences for the parental DTSQ scores between groups, after adjusting for age and household income. However, analysis of the child DTSQ scores showed notable differences. When compared to the tertiary <1-hour group, the tertiary >2-hour group had significantly lower DTSQ scores (score difference − 7.24; 95% CI: −11.86, −2.63, P = 0.003) (Table 3) . Similarly, when compared to the community group, the tertiary >2-hour group again had significantly lower satisfaction (score difference − 6.37; 95% CI: −11.04, −1.70, Abbreviations: ADQ, adherence in diabetes questionnaire; BCCH, British Columbia Children's Hospital; CSII, continuous subcutaneous insulin infusion; DTSQ, diabetes treatment satisfaction questionnaire; F, father; HbA1c, hemoglobin A1 C ; M, mother; MDI, multiple daily injections; T1D, type 1 diabetes. a Sample size: BCCH <1 hour, n = 40; BCCH 1 to 2 hours, n = 15; BCCH >2 hours, n = 15; community, n = 40. b Sample size: BCCH <1 hour, n = 30; BCCH 1 to 2 hours, n = 9; BCCH >2 hours, n = 9; community, n = 27.
access to nursing support on weekdays via email, fax, and phone, regardless of their location. However, it is possible that the families traveling >2 hours to attend a tertiary diabetes clinic felt less connected to their care team, and thus did not utilize these services as Consistent with prior research, we found that community patients visited clinic more often than tertiary patients. 4 This may have contributed to the differences in HbA 1C between the community and >2-hour tertiary groups, yet it would not account for the differences between the <1-hour and > 2-hour tertiary groups, as they had a similar number of visits per year. The differences cannot be attributed to the use of CSII, as the BCCH 1-to 2-hour group had the lowest percentage of CSII patients and despite this, the mean HbA 1C in this group was similar to the BCCH <1-hour and community groups.
Furthermore, the discrepancy in outcomes is unlikely to be the result of a referral bias to the tertiary care center. As highlighted earlier, 77% of community patients were receiving care from a pediatric endocrinologist, and it is not common practice for these subspecialists to refer complex patients to BCCH, unless they are in need of other subspecialty services. In addition to distance to care, there may be unknown confounders that could help to explain this discrepancy in outcomes for children traveling longer to access diabetes care. Further research focusing on patient-reported outcomes should explore what other factors may be contributing to our findings.
Although the association between travel time to clinic and pediatric type 1 diabetes outcomes has not been previously explored, other investigators have compared the outcomes for patients seen at tertiary care centers and those seen in outreach clinics. In Australia, Joshi et al 8 found that HbA 1C was similar in both groups, as were rates of diabetic ketoacidosis. Another Australian study investigated the same issue, and also found comparable HbA 1C values over a 6-year period in the tertiary and outreach patients. 4 In their model of care, outreach was provided by a pediatric endocrinologist who worked with the local diabetes care team, including a nurse educator and dietitian. 4 Cameron et al 9 compared glycemic control for patients seen in a tertiary center compared to regional clinics. The median HbA 1C values were higher in the regional clinics; however, the differences were not statistically significant, likely related to the small sample sizes at the regional clinics (n = 13-18). Different from our study, the regional patients were primarily managed by general practitioners and pediatricians. 9 Satisfaction with care was not formally assessed in the aforementioned studies.
One of the major strengths of this study was our use of patientreported travel time rather than distance to clinic. This is particularly important in BC, as our geography is highly variable. Another strength was our ability to incorporate caregiver perspectives on barriers to care. Limitations included our smaller sample size for the groups traveling 1 to 2 hours and >2 hours to BCCH. We also recognize that the HbA 1C results were run on different assays. However, all laboratories in BC conform to the National Glycohemoglobin Standardization Program guidelines. 10 Finally, patients were not involved in the development of the list of barriers, a further limitation of this study.
| CONCLUSION
Our findings suggest that T1D patients traveling long distances to clinic would benefit from care closer to home. Community care has the potential to improve glycemic control, reduce barriers to accessing medical services, and enhance satisfaction with care. This information can be used to re-evaluate current policies related to T1D models of care. With these results, decision-makers can advocate for resources to expand outreach efforts and enhance local capacity to deliver T1D care, bolstering providers ability to deliver high-quality, communitybased care. Further research should explore whether these findings can be replicated in other geographic and health system contexts and why care closer to home is associated with better glycemic control and satisfaction with care.
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